Fulcrum Therapeutics, Inc. · Brief

Next report

7 days

Nov 9 · before openest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

0 of 7≥ implied

Nov 13 '24—▼−2.20%—

Jan 13 '25±17.6%▼−4.58%×0.26

Feb 25 '25±16.3%0.00%×0.00

May 1 '25±36.6%▲+13.77%×0.38

Jul 29 '25±44.9%▼−2.82%×0.06

Oct 29 '25±18.7%▼−6.40%×0.34

Feb 24 '26±29.8%▼−21.21%×0.71

Q1 FY26±19.3%▼−1.53%×0.08

quarterimplied−45%0+45%realized×

Q1 FY26±19.3%▼−1.53%×0.08

Feb '26±29.8%▼−21.21%×0.71

Oct '25±18.7%▼−6.40%×0.34

Jul '25±44.9%▼−2.82%×0.06

May '25±36.6%▲+13.77%×0.38

Feb '25±16.3%0.00%×0.00

2 older reports

Jan '25±17.6%▼−4.58%×0.26

Nov '24—▼−2.20%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 9 report · est.

Bull2 of 3

3disclosed supplier and customer ties in SEC filingsSEC filings

3tracked funds holding FULCN-PORT · Aug 31 '26

Bear1

7 of 7recent reports where the move came in under the options-implied rangeEarnings history

AI captions · Sep 16 '26once per report · top 2 per case

FULC report session

No linked exposure.

Oct 27impliedImplied move: ±16.7% into Nov 9 earnings (Oct 27 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.